Moderna annual gross profit
2018
2019
2020
2021
2022
2023
2024
2025
Moderna Gross Profit Growth & History (MRNA)
Moderna's gross profit was $1.08B for fiscal 2025.
View full Moderna company overviewModerna annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.08B | −$696.0M | −39.28% |
| 2024 | 2024-12-31 | $1.77B | −$383.0M | −17.77% |
| 2023 | 2023-12-31 | $2.15B | −$11.69B | −84.44% |
| 2022 | 2022-12-31 | $13.85B | −$2.01B | −12.66% |
| 2021 | 2021-12-31 | $15.85B | $15.06B | +1894.21% |
| 2020 | 2020-12-31 | $795.0M | $734.8M | +1220.40% |
| 2019 | 2019-12-31 | $60.2M | −$74.9M | −55.42% |
| 2018 | 2018-12-31 | $135.1M | — | — |
Moderna quarterly gross profit
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross profit | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $52.0M | $29.0M | +126.09% |
| Q1 2026 | 2026-03-31 | −$566.0M | −$584.0M | — |
| Q4 2025 | 2025-12-31 | $226.0M | −$1.0M | −0.44% |
| Q3 2025 | 2025-09-30 | $809.0M | −$539.0M | −39.99% |
| Q2 2025 | 2025-06-30 | $23.0M | −$103.0M | −81.75% |
| Q1 2025 | 2025-03-31 | $18.0M | −$53.0M | −74.65% |
| Q4 2024 | 2024-12-31 | $227.0M | −$1.66B | −87.94% |
| Q3 2024 | 2024-09-30 | $1.35B | $1.76B | — |
| Q2 2024 | 2024-06-30 | $126.0M | $513.0M | — |
| Q1 2024 | 2024-03-31 | $71.0M | −$999.0M | −93.36% |
| Q4 2023 | 2023-12-31 | $1.88B | −$1.28B | −40.56% |
| Q3 2023 | 2023-09-30 | −$410.0M | −$2.67B | — |
| Q2 2023 | 2023-06-30 | −$387.0M | −$3.75B | — |
| Q1 2023 | 2023-03-31 | $1.07B | −$3.98B | −78.81% |
| Q4 2022 | 2022-12-31 | $3.17B | −$3.09B | −49.42% |
| Q3 2022 | 2022-09-30 | $2.26B | −$1.98B | −46.69% |
| Q2 2022 | 2022-06-30 | $3.37B | −$236.0M | −6.55% |
| Q1 2022 | 2022-03-31 | $5.05B | $3.31B | +189.51% |
| Q4 2021 | 2021-12-31 | $6.26B | $5.70B | +1011.72% |
| Q3 2021 | 2021-09-30 | $4.25B | $4.09B | +2605.10% |
| Q2 2021 | 2021-06-30 | $3.60B | $3.54B | +5279.10% |
| Q1 2021 | 2021-03-31 | $1.74B | $1.74B | +21700.00% |
| Q4 2020 | 2020-12-31 | $563.0M | — | — |
| Q3 2020 | 2020-09-30 | $157.0M | — | — |
| Q2 2020 | 2020-06-30 | $67.0M | — | — |
| Q1 2020 | 2020-03-31 | $8.0M | — | — |
Moderna gross profit trends
Over the last five fiscal years, Moderna's gross profit increased from $795.0M to $1.08B, a change of $281.0M. The latest reported quarter, Q2 2026, shows $52.0M.
About the metric
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
Calculation and source
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Moderna source filings ↗